Guijie Xin

机构：Jilin University, Changchun Observatory, First Hospital of Jilin University, First Bethune Hospital of Jilin University · ORCID：0000-0002-0868-0317

发表论文 26 篇 · 总被引 170 次 · h-index 5

代表论文

• Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies (2010 · Cellular and Molecular Immunology · 被引 43)
• Associations of five dietary indices with metabolic dysfunction-associated steatotic liver disease and liver fibrosis among the United States population (2024 · Frontiers in Nutrition · 被引 18)
• Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study (2025 · Hepatology · 被引 10)
• Influence of genetically predicted autoimmune diseases on NAFLD (2023 · Frontiers in Immunology · 被引 10)
• Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study (2025 · Clinical Cancer Research · 被引 4)
• A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites (2025 · Hepatology International · 被引 3)